AGER and neoplasm: Besides, several pre-existing pathological conditions, such as chronic inflammatory, hyperglycemic, hypoxia, and glycoxidative stress, in conjunction with the activation of the receptor for advanced glycation end products (RAGE)-ligand would synergistically promote tumor development and progression, mostly in diabetic and obese patients [12].